Muse cell
A Muse cell (Multi-lineage differentiating stress-enduring cell) is an endogenous non-cancerous pluripotent stem cell.
≈ 7 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
A Muse cell (Multi-lineage differentiating stress-enduring cell) is an endogenous non-cancerous pluripotent stem cell. They reside in the connective tissue of nearly every organ including the umbilical cord, bone marrow and peripheral blood, and are collectable from commercially obtainable mesenchymal cells such as human fibroblasts, bone marrow-mesenchymal stem cells and adipose-derived stem cells as 1~several percent of the total population.
Muse cells are able to generate cells representative of all three germ layers from a single cell both spontaneously and under cytokine induction. Expression of pluripotency genes and triploblastic differentiation are self-renewable over generations. Muse cells do not undergo teratoma formation when transplanted into a host environment in vivo.
This can be explained in part by their intrinsically low telomerase activity, eradicating the risk of tumorigenesis through unbridled cell proliferation. They were discovered in 2010 by Mari Dezawa and her research group.
Clinical trials for acute myocardial infarction, stroke, epidermolysis bullosa, spinal cord injury, amyotrophic lateral sclerosis, acute respiratory distress syndrome (ARDS) related to novel coronavirus (SARS-CoV-2) infection, are conducted. A hysician-led clinical trial for neonatal hypoxic-ischemic encephalopathy was also started.…
A Muse cell (Multi-lineage differentiating stress-enduring cell) is an endogenous non-cancerous pluripotent stem cell. They reside in the connective tissue of nearly every organ including the umbilical cord, bone marrow and peripheral blood, and are collectable from commercially obtainable mesenchymal cells such as human fibroblasts, bone marrow-mesenchymal stem cells and adipose-derived stem cells as 1~several percent of the total population.
Muse cells are able to generate cells representative of all three germ layers from a single cell both spontaneously and under cytokine induction. Expression of pluripotency genes and triploblastic differentiation are self-renewable over generations. Muse cells do not undergo teratoma formation when transplanted into a host environment in vivo.
This can be explained in part by their intrinsically low telomerase activity, eradicating the risk of tumorigenesis through unbridled cell proliferation. They were discovered in 2010 by Mari Dezawa and her research group.
Clinical trials for acute myocardial infarction, stroke, epidermolysis bullosa, spinal cord injury, amyotrophic lateral sclerosis, acute respiratory distress syndrome (ARDS) related to novel coronavirus (SARS-CoV-2) infection, are conducted. A hysician-led clinical trial for neonatal hypoxic-ischemic encephalopathy was also started.
The summary results of a randomized double-blind placebo-controlled clinical trial in patients with stroke was announced.
In vitro
Muse cells can differentiate into: Ectodermal- (cells positive for nestin, NeuroD, Musashi, neurofilament, MAP-2, melanocyte markers (tyrosinase, MITF, gf100, TRP-1, DCT) ), Mesodermal- (brachyury, Nkx2-5, smooth muscle actin, osteocalcin, oil red-(+) lipid droplets, desmin ) Endodermal- (GATA-6, α-fetoprotein, cytokeratin-7, albumin ) lineages both spontaneously and under cytokine induction. After homing to damage tissue by S1P-S1PR2, Muse cells phagocytose damaged cells, similar to macrophages.
They then recycle the differentiation signals (e.g., transcription factors) obtained from the damaged cells and rapidly differentiate into the same cell type as the damaged cell.
In vivo
Muse cells are shown to home into the damage site by S1P-S1P receptor 2 axis and spontaneously differentiate into tissue-compatible cells according to the microenvironment to contribute to tissue regeneration when infused into the blood stream as shown in animal models with fulminant hepatitis, partial hepatectomy, muscle degeneration, epidermolysis bullosa, skin injury, stroke and spinal cord injury. The spontaneous differentiation into tissue-compatible cells was explained by the phagocytosis-dependent differentaition: after homing to damaged tissue, Muse cells phagocytose damaged cells, similar to macrophages, recycle the differentiation signals (e.g., transcription factors) obtained from the damaged cells and rapidly differentiate into the same cell type as the damaged cell.
Low telomerase activity
Muse cells are characterized by low telomerase activity, not a strong indicator of tumorigenicity. Hela cells and human fibroblast-derived iPS cells showed high telomerase activity while Muse was at nearly the same level as that in somatic cells such as fibroblasts (these data are shown without running control for the telomerase activity, the comparison is not scientific thought). This indicates the non-tumorigenic nature of Muse cells.
Expression of genes related to pluripotency and cell cycle
The expression 'pattern' of genes related to pluripotency in Muse cells was almost the same as that in ES and iPS cells, while the expression 'level' was much higher in ES and iPS cells and that in Muse cells. In contrast, genes related to cell cycle progression and tumorigenicity in Muse cells were at the same level as those in somatic cells, while the same genes were very high in ES and iPS cells.
These gene expression pattern and level may explain why Muse cells are pluripotent but without tumorigenic activity.
Transplantation into mouse testes
Unlike ES and iPS cells, transplanted Muse cells in testes of immunodeficient mice -a commonly used experiment to test the tumorigenicity of stem cells- have not been reported to form teratomas, even after six months. Thus, Muse cells are pluripotent but are non-tumorigenic.
Similarly, epiblast stem cells cultured under certain conditions also do not form teratomas in testes, even though they show pluripotency in vitro. Thus, pluripotent stem cells do not always show teratoma formation when transplanted in vivo.
Location in vivo
Muse cells are not generated by stress, cytokine induction or exogenous gene transfection. They are preexisting pluripotent stem cells that normally reside in the bone marrow, peripheral blood and connective tissue of every organ including the umbilical cord. [3][1][4][5][6] ] In the bone marrow, they represent one out of 3000 mono-nucleated cells.
Other than mesenchymal tissues, Muse cells locate in connective tissue of every organ and in the peripheral blood.
Formation of clusters similar to embryoid body of ES cells in suspension
In cell suspension, Muse cells begin to proliferate and to form clusters that are very similar to embryoid bodies formed from ES cells in suspension. Muse cell clusters are positive for pluripotency indicators such as alkaline phosphatase reactivities, Nanog, Oct3/4, Sox2 and PAR4.
One of remarkable properties of Muse cells is that they are capable of forming clusters from a single cell in suspension. A single Muse cell-derived cluster is shown to spontaneously generate cells representative of all three germ layers on a gelatin-coated dish, proving the pluripotency of Muse cells.
Proliferation speed
Muse cells proliferate at a speed of ~1.3 day/cell division in adherent culture. This is slightly slower than that of human fibroblasts (~1 day/cell division).
Amyotrophic lateral sclerosis model
In G93A-transgenic ALS mice, intravenous injection of 5.0 × 10^4 Muse cells revealed successful homing to the lumbar spinal cords, mainly at the pia-mater and underneath white matter, and exhibited glia-like morphology and GFAP expression. In contrast, such homing or differentiation were not recognized in human mesenchymal stem cells but were instead distributed mainly in the lung.
Relative to the vehicle groups, the Muse group significantly improved scores in the rotarod, hanging-wire and muscle strength of lower limbs, recovered the number of motor neurons, and alleviated denervation and myofiber atrophy in lower limb muscles. These results suggest that Muse cells homed in a lesion site-dependent manner and protected the spinal cord against motor neuron death.
See also
Stimulus-triggered acquisition of pluripotency cell Induced stem cells
Text derived from https://en.wikipedia.org/w/index.php?oldid=1368885320 under CC BY-SA 4.0; modifications have been made.